Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

I guess the worst-case scenario is Verséa Ophthalmics is insolvent and Verséa Health needs to cut that division.

Without CLIA waiver approvals Verséa Ophthalmics and AXIM are both burning a lot of cash. Adding just one paying customer a week seems like it will take too long to be cash-flow positive.

In that case maybe Mr Huemoeller does change gears and try to market the TPOC Tear-based Point-of-Care Parkinson Disease test.

I guess anything is possible at this point.

I guess we will know soon enough.

Good luck to all.
Not investment advice.